California Nanotechnologies Corp.
CANOF
$0.25
$0.00-1.19%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -21.59% | -78.27% | -48.76% | -59.02% | 16.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.59% | -78.27% | -48.76% | -59.02% | 16.73% |
| Cost of Revenue | 0.37% | -21.04% | 10.89% | -48.43% | 41.11% |
| Gross Profit | -31.36% | -95.54% | -61.52% | -64.55% | 8.39% |
| SG&A Expenses | -24.28% | 14.19% | 20.66% | 47.92% | 45.15% |
| Depreciation & Amortization | -7.93% | 14.28% | 46.61% | 50.30% | 421.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.76% | 1.87% | 21.16% | -1.68% | 58.29% |
| Operating Income | 3.10% | -235.50% | -159.71% | -171.73% | -23,982.35% |
| Income Before Tax | 84.49% | -1,064.28% | 55.30% | -164.35% | 62.22% |
| Income Tax Expenses | -100.00% | -- | -- | -- | 18,777.78% |
| Earnings from Continuing Operations | 92.83% | -1,067.90% | 55.36% | -164.35% | 18.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.83% | -1,067.90% | 55.36% | -164.35% | 18.07% |
| EBIT | 3.10% | -235.50% | -159.71% | -171.73% | -23,982.35% |
| EBITDA | 4.00% | -209.74% | -143.17% | -155.00% | -1,433.47% |
| EPS Basic | 91.18% | -1,020.00% | 57.82% | -161.15% | 25.27% |
| Normalized Basic EPS | 80.00% | -993.75% | 58.51% | -161.22% | 64.91% |
| EPS Diluted | 91.18% | -1,145.45% | 57.82% | -196.00% | 25.27% |
| Normalized Diluted EPS | 80.00% | -1,121.43% | 56.79% | -158.24% | 64.91% |
| Average Basic Shares Outstanding | -13.52% | 6.00% | 5.45% | 5.50% | 9.01% |
| Average Diluted Shares Outstanding | -13.52% | -7.66% | 0.25% | 9.95% | 9.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |